<p>Survival curves for the endpoints death from CHD and incidence of HF according to the biomarker quarters. The p-value shown is for the logrank test.</p
Survival curves for (A) all-cause mortality, (B) cardiovascular disease (CVD) related mortality, (C)...
<p>Cumulative survival rates in relation to histologic type, together with the p value from the log-...
<p>Survival curves for death and cardiovascular events in patients treated with statin or fibrate mo...
<p>Survival curves for (A) time to death from any cause, (B) cardiovascular death, (C) sudden death,...
<p>Survival curves for in-hospital mortality in the geriatric (Panel A) and orthopedic (Panel B) coh...
<p>Survival curves in relation to inhibin B levels (p = 0,00625, log-rank test).</p
Kaplan-Meier curves of overall survival for patients stratified by (A) FN intensity (0 vs > 0) and (...
<p>Survival curves in relation to inhibin A levels (p = 0,46, log-rank test).</p
<p>Kaplan-Meir survival curves for the risk of all-cause death in the study participants for all par...
<p>Survival curve showing the time to post-discharge death and the events versus number at risk of s...
<p>(A) Disease free survival (log-rank test, p-value = 0.0016). (B) Disease specific survival (log-r...
<p>Longitudinal biomarker measurements: Hazard ratios for death from CHD estimated by joint models.<...
Kaplan-meier survival curves based on the primary clinical endpoint on day 14 using the log rank tes...
<p>Cox models were adjusted for age (as the time scale), sex, overweight (BMI > 25 kg/m<sup>2</sup>)...
<p>Fully adjusted survival curves for CVD mortality by HbA1<sub>C</sub> and diabetes category (whole...
Survival curves for (A) all-cause mortality, (B) cardiovascular disease (CVD) related mortality, (C)...
<p>Cumulative survival rates in relation to histologic type, together with the p value from the log-...
<p>Survival curves for death and cardiovascular events in patients treated with statin or fibrate mo...
<p>Survival curves for (A) time to death from any cause, (B) cardiovascular death, (C) sudden death,...
<p>Survival curves for in-hospital mortality in the geriatric (Panel A) and orthopedic (Panel B) coh...
<p>Survival curves in relation to inhibin B levels (p = 0,00625, log-rank test).</p
Kaplan-Meier curves of overall survival for patients stratified by (A) FN intensity (0 vs > 0) and (...
<p>Survival curves in relation to inhibin A levels (p = 0,46, log-rank test).</p
<p>Kaplan-Meir survival curves for the risk of all-cause death in the study participants for all par...
<p>Survival curve showing the time to post-discharge death and the events versus number at risk of s...
<p>(A) Disease free survival (log-rank test, p-value = 0.0016). (B) Disease specific survival (log-r...
<p>Longitudinal biomarker measurements: Hazard ratios for death from CHD estimated by joint models.<...
Kaplan-meier survival curves based on the primary clinical endpoint on day 14 using the log rank tes...
<p>Cox models were adjusted for age (as the time scale), sex, overweight (BMI > 25 kg/m<sup>2</sup>)...
<p>Fully adjusted survival curves for CVD mortality by HbA1<sub>C</sub> and diabetes category (whole...
Survival curves for (A) all-cause mortality, (B) cardiovascular disease (CVD) related mortality, (C)...
<p>Cumulative survival rates in relation to histologic type, together with the p value from the log-...
<p>Survival curves for death and cardiovascular events in patients treated with statin or fibrate mo...
DOI
Add to ORKG